# EDGAR Filing Document

**Accession Number:** 0001880343
**File Stem:** 0001554795-25-000176
**Filing Date:** 2025-7
**Character Count:** 43174
**Document Hash:** d8abcd951cda8b79e66a59720f1fe9fa
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001554795-25-000176.hdr.sgml**: 20250715

**ACCESSION NUMBER**: 0001554795-25-000176

**CONFORMED SUBMISSION TYPE**: 8-K

**PUBLIC DOCUMENT COUNT**: 14

**CONFORMED PERIOD OF REPORT**: 20250711

**ITEM INFORMATION**: Entry into a Material Definitive Agreement

**ITEM INFORMATION**: Unregistered Sales of Equity Securities

**ITEM INFORMATION**: Regulation FD Disclosure

**ITEM INFORMATION**: Financial Statements and Exhibits

**FILED AS OF DATE**: 20250715

**DATE AS OF CHANGE**: 20250715

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** AMAZE HOLDINGS, INC.
- **CENTRAL INDEX KEY:** 0001880343
- **STANDARD INDUSTRIAL CLASSIFICATION:** RETAIL-EATING PLACES [5812]
- **ORGANIZATION NAME:** 07 Trade & Services
- **EIN:** 873905007
- **STATE OF INCORPORATION:** NV
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 8-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-41147
- **FILM NUMBER:** 251124871

**BUSINESS ADDRESS:**
- **STREET 1:** 2901 WEST COAST HWY
- **STREET 2:** SUITE 200
- **CITY:** NEWPORT BEACH
- **STATE:** CA
- **ZIP:** 92663
- **BUSINESS PHONE:** 855-766-9463

**MAIL ADDRESS:**
- **STREET 1:** 2901 WEST COAST HWY
- **STREET 2:** SUITE 200
- **CITY:** NEWPORT BEACH
- **STATE:** CA
- **ZIP:** 92663

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Fresh Vine Wine, Inc.
- **DATE OF NAME CHANGE:** 20211208

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** FRESH GRAPES, LLC
- **DATE OF NAME CHANGE:** 20210826

?xml version='1.0' encoding='ASCII'?

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

**FORM 8-K**

**CURRENT REPORT**

**Pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934**

**Date of Report (Date of earliest event reported): July 11, 2025**

**AMAZE HOLDINGS, INC.**

**(Exact name of registrant as specified in its charter)**

---

| | | |
|:---|:---|:---|
| **Nevada** | **001-41147** | **87-3905007** |
| (State or other jurisdiction <br> of incorporation) | (Commission <br> File Number) | (I.R.S. Employer <br> Identification No.) |

---

---

| | |
|:---|:---|
| **2901 West Coast Highway, Suite 200**<br> **Newport Beach, CA**<br>| **92663** |
| (Address of principal executive offices) | (Zip Code) |

---

**(855) 766-9463**

Registrant's telephone number, including area code

**Fresh Vine Wine, Inc.**

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation to the registrant under any of the following provisions:

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) <br>☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

---

| | | |
|:---|:---|:---|
| **Title of each class** | **Trading Symbol(s)** | **Name of each exchange on which registered** |
| Common stock, par value $0.001 per share | AMZE | NYSE American |

---

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 or Rule 12b-2 of the Securities Exchange Act of 1934.

Emerging growth company ☑

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

**Item 1.01. Entry Into a Material Definitive Agreement.**

On July 11, 2025, Amaze Holdings, Inc. (the "Company") entered into a consulting agreement with DNA Holdings Venture Inc., a Puerto Rico corporation ("Consultant"), pursuant to which Consultant will provide strategic advisory services to the Company, including but not limited to crypto strategy and token architecture; e-commerce and web3 integration; globalization and cross-border currency solutions; credibility and visibility; and token launch and market support. The Company agreed to engage DNA Market Making as one of the Company's market-making providers for its Token Generation Event. The consulting agreement has a 12 month term, which extends for an additional 12 months unless terminated earlier by either party upon 30 days written notice.

As consideration for the advisory services, the Company issued to Consultant 100,000 shares of the Company's common stock.

The foregoing description of the consulting agreement is not complete and is qualified in its entirety by reference to the full text of the document, which is filed as Exhibit 10.1 to this Current Report on Form 8-K and is incorporated herein by reference.

**Item 3.02 Unregistered Sales of Equity Securities.**

The information set forth in Item 1.01 of this Current Report on Form 8-K is incorporated herein by reference. The shares of common stock were offered and sold to Consultant in reliance upon exemptions from registration pursuant to Section 4(a)(2) under the Securities Act of 1933, as amended (the "Securities Act"), and/or Rule 506(b) of Regulation D promulgated thereunder, as transactions by an issuer not involving any public offering.

**Item 7.01. Regulation FD Disclosure**

On July 15, 2025, the Company issued a press release announcing the consulting agreement. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K.

The information in Item 7.01 of this Current Report on Form 8-K and in Exhibit 99.1 attached hereto shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act or the Exchange Act, except as expressly set forth by specific reference in such a filing.

**Item 9.01 Financial Statements and Exhibits**

(d) Exhibits.

---

| | |
|:---|:---|
| **Exhibit No.** | **Description** |
| [10.1](amze0715form8kexh10_1.htm) | [Consulting Agreement dated July 11, 2025 between Amaze Holdings, Inc. and DNA Holdings Venture Inc.](amze0715form8kexh10_1.htm) |
| [99.1](amze0715form8kexh99_1.htm) | [Press release dated July 15, 2025](amze0715form8kexh99_1.htm) |
| 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document) |

---

**SIGNATURE**

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

---

| | | |
|:---|:---|:---|
| Dated: July 15, 2025 |  |  |
|  | **AMAZE HOLDINGS, INC.** | **AMAZE HOLDINGS, INC.** |
|  | By: | /s/ Aaron Day |
|  | Name: | Aaron Day |
|  | Title: | Chief Executive Officer |

---

## Exhibit 10.1

**Exhibit 10.1**

**DNA Holdings Venture Inc.**

**DNA CONSULTING AGREEMENT**

This Consulting Agreement (the "*Agreement*") is entered into on July 11, 2025 (the "<u>Eﬀective Date</u>") by and between **Amaze** (the "*Company*"), and DNA Holdings Venture Inc, a Puerto Rico Corporation (the "*Consultant*"). In this Agreement, the Company and Consultant may each be referred to as a "party" or, together, as the "parties." Now therefore, the parties hereby agree as follows:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1. <u>**Consulting Relationship**</u>**.** During the term of this Agreement, Consultant will provide consulting services (the "***Services***") to the Company as described on <u>Exhibit</u> <u>A</u> attached to this Agreement. Consultant represents that it has the qualiﬁcations, the experience and the ability to properly perform the Services. Consultant shall use Consultant's best eﬀorts to perform the Services such that the results are satisfactory to the Company.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2. <u>**Compensation**</u>**.** As consideration for the Services to be provided by Consultant and other obligations, the Company shall pay to Consultant the amounts speciﬁed in <u>Exhibit C</u> attached to this Agreement at the times speciﬁed therein.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3. <u>**Expenses**</u>**.** Consultant shall not be authorized to incur on behalf of the Company any expenses without the prior consent of the Company's Chief Executive Officer, which consent shall be evidenced in writing for any expenses in excess of $200. As a condition to receipt of reimbursement, Consultant shall be required to submit to the Company reasonable evidence that the amount involved was expended and related to Services provided under this Agreement.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4. <u>**Term and Termination**</u>**.** Consultant shall serve as a consultant to the Company for a twelve month period commencing on the Eﬀective Date of this Agreement (the "***Term***"). The Term shall be extended for an additional twelve months unless terminated by either party with 30 days written notice.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5. <u>**Independent Contractor**</u>**.** Consultant's relationship with the Company will be that of an independent contractor and not that of an employee. Consultant shall be responsible for the payment of any federal, state or local taxes due by Consultant.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) <u>**Method of Provision of Services**</u>**:** Consultant shall be solely responsible for determining the method, details and means of performing the Services. Consultant may, at Consultant's own expense, employ or engage the service of such employees or subcontractors as Consultant deems necessary to perform the Services required by this Agreement (the "***Assistants***"). Such Assistants are not the employees of the Company and Consultant shall be wholly responsible for the professional performance of the Services by its Assistants such that the results are satisfactory to the Company. Consultant shall expressly advise the Assistants of the terms of this Agreement, and shall require each Assistant to execute a Conﬁdential Information and Inventions Agreement (the "***Conﬁdentiality Agreement***") with terms at least as protective of the Company as set forth in Sections 7 and 8 hereof.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) <u>**No Authority to Bind Company**</u>**.** Neither Consultant, nor any partner, agent or employee of Consultant, has authority to enter into contracts that bind the Company or create obligations on the part of the Company without the prior written authorization of the Company. Consultant shall not be an agent of the Company.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) <u>**No Beneﬁts**</u>**.** Consultant acknowledges and agrees that Consultant (or Consultant's employees, if Consultant is an entity) will not be eligible for any Company employee beneﬁts and, to the extent Consultant (or Consultant's employees, if Consultant is an entity) otherwise would be eligible for any Company employee beneﬁts but for the express terms of this Agreement, Consultant (on behalf of itself and its employees) hereby expressly declines to participate in such Company employee beneﬁts.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) <u>**Withholding; Indemniﬁcation**</u>**.** Consultant shall have full responsibility for applicable withholding taxes for all compensation paid to Consultant, its partners, agents or its employees under this Agreement, and for compliance with all applicable labor and employment requirements with respect to Consultant's self-employment, sole proprietorship or other form of business organization, and Consultant's partners, agents and employees, including state worker's compensation insurance coverage requirements and any US immigration visa requirements. Consultant agrees to indemnify, defend and hold the Company harmless from any liability for, or assessment of, any claims or penalties with respect to such withholding taxes, labor or employment requirements, including any liability for, or assessment of, withholding taxes imposed on the Company by the relevant taxing authorities with respect to any compensation paid to Consultant or Consultant's partners, agents or its employees.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6. <u>**Supervision of Consultant's Services**</u>**.** All of the services to be performed by Consultant, including but not limited to the Services, will be as agreed between Consultant and the Company**.** Consultant will be required to report to the company concerning the Services performed under this Agreement. The nature and frequency of these reports will be left to the discretion of the Company.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;7. <u>**Company Property**</u>**.** (a) <u>**Deﬁnition**</u>**.** For the purposes of this Agreement, the term "Company Inventions" will mean all inventions, works of authorship, reports, improvements, developments, concepts or trade secrets made, conceived, developed or reduced to practice by Consultant, alone or with others, whether or not patentable or otherwise legally protectable, which result from the performance of the Services or which have been funded by the Company.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) <u>Assignment of Ownership</u>.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) <u>**Assignment**</u>**.** Consultant hereby acknowledges and agrees that all Company Inventions shall be considered 'work made for hire' to the maximum extent permitted by law. To the extent any Company Invention does not qualify as a work

made for hire, Consultant hereby assigns to the Company all right, title, and interest therein, and waives any moral rights thereto.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii) <u>**Disclosure, Assistance and Conﬁdentially**</u>**.** Consultant will: (A) disclose all Company Inventions to the Company promptly, in writing; (B) cooperate with and assist the Company to apply for and to prosecute, and to execute any applications, assignments or other documents reasonably necessary to obtain or maintain, any patent, copyright, trademark or other statutory protection for all applicable Company Inventions in the Company's name as the Company deems appropriate; (C) deliver to the Company evidence for interference purposes or other legal proceedings and to testify in any interference or other legal proceedings and to otherwise assist the Company related thereto, whenever reasonably requested to do so by the Company; and (D) treat all Company Inventions as "Conﬁdential Information," as deﬁned below. Consultant hereby grants the Company a limited power of attorney to execute any documents necessary or appropriate to eﬀectuate the Company's rights hereunder.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;8. <u>Conﬁdentiality</u>.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) <u>**Scope**</u>**.** Consultant will protect the Conﬁdential Information (as deﬁned below) from unauthorized dissemination and use. Consultant will not use the Conﬁdential Information for purposes other than the performance of the Services. Consultant will not disclose to third parties the Conﬁdential Information without the prior written consent of the Company. For purposes of this Agreement, "***Conﬁdential Information***" means any trade secrets or other information of the Company, whether of a business, ﬁnancial, technical or other nature (including, without limitation, information relating to the Company's products, research, development, intellectual property, business plans, ﬁnances, marketing plans, suppliers, vendors, customers, clients, prospects or other aﬀairs), that is disclosed to or observed by Consultant during the term of this Agreement. Conﬁdential Information also includes any information that has been made available to the Company by third parties that the Company is obligated to keep conﬁdential. Conﬁdential Information does not include any information that Consultant can establish: (i) is or was acquired by Consultant from a third party and is not subject to an unexpired obligation to such third party restricting Consultant's use or disclosure thereof; (ii) is independently developed by Consultant without reliance upon or use of the Conﬁdential Information; or (iii) is or has become generally publicly available through no fault or action of Consultant.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) <u>**Exception**</u>**.** Notwithstanding Section 8(a), Consultant may disclose or produce any Conﬁdential Information if and to the extent required by any discovery request, subpoena, court order or governmental action; provided, that Consultant gives the Company reasonable advance notice of the same (e.g., so as to aﬀord the Company a reasonable opportunity to appear, object and obtain a protective order or other appropriate relief regarding such disclosure).

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;9. <u>Conﬂicts with this Agreement</u>.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) <u>**Third Party Products**</u>. Consultant represents and warrants that neither Consultant nor any of Consultant's partners, employees or agents is under any pre-existing obligation in conﬂict or in any way inconsistent with the provisions of this Agreement. Consultant represents and warrants that Consultant's performance of all the terms of this Agreement will not breach any agreement to keep in conﬁdence proprietary information acquired by Consultant in conﬁdence or in trust prior to commencement of this Agreement. Consultant warrants that Consultant has the right to disclose and/or or use all ideas, processes, techniques and other information, if any, which Consultant has gained from third parties, and which Consultant discloses to the Company or uses in the course of performance of this Agreement, without liability to such third parties. Notwithstanding the foregoing, Consultant agrees that Consultant shall not bundle with or incorporate into any deliveries provided to the Company herewith any third party products, ideas, processes, or other techniques, without the express, written prior approval of the Company. Consultant represents and warrants that Consultant has not granted and will not grant any rights or licenses to any intellectual property or technology that would conﬂict with Consultant's obligations under this Agreement. Consultant will not knowingly infringe upon any copyright, patent, trade secret or other property right of any former client, employer or third party in the performance of the Services required by this Agreement. Consultant shall fully indemnify and hold harmless the Company for any breach under this Section 9.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) <u>**Potential Conﬂict of Interest Disclosure Policy**</u>. To the extent a relationship between Consultant and a 3<sup>rd</sup> party or client of Company may pose a conﬂict of interest with the Company, including any additional consideration exchange such as payment of expenses or additional compensation, Company requires Consultants' provide a full, forthcoming, and material disclosure of this conﬂict or potential conﬂict of interests. Company may terminate Consultants' contract for Cause, should consultant fail to disclose a conﬂict of interest. Company also reserves the right to determine when and upon what terms a conﬂict of interest will be permitted between Consultants and 3<sup>rd</sup> parties, and to what extent consulting and investment relationships may be permitted with clients outside of the scope of this Agreement. If such an ongoing relationship is permitted, Consultant will be under strict requirements to report any change to the circumstance or nature of the relationship that may be considered material to Company's interests.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;10. <u>Miscellaneous</u>.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) <u>**Amendments and Waivers**</u>**.** Any term of this Agreement may be amended or waived only with the written consent of the parties.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) <u>**Sole Agreement**</u>**.** This Agreement, including the Exhibits hereto, constitutes the sole agreement of the parties and supersedes all oral negotiations and prior writings with respect to the subject matter hereof.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) <u>**Notices**</u>**.** Any notice required or permitted by this Agreement shall be in writing and shall be deemed suﬃcient upon receipt, when delivered personally or by courier, overnight delivery service or conﬁrmed facsimile, 48 hours after being deposited in the regular mail as certiﬁed or registered mail (airmail if sent internationally) with postage prepaid, if such notice is addressed to the party to be notiﬁed at such party's address or facsimile number as set forth below, or as subsequently modiﬁed by written notice.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) <u>**Choice of Law**</u>**.** The validity, interpretation, construction and performance of this Agreement shall be governed by the laws of the the state of Delaware, without giving eﬀect to the principles of conﬂict of laws.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e) <u>**Severability**. If one or more provisions of this Agreement are held to be unenforceable under applicable law, the parties agree to renegotiate such provision in good faith. In the event that the parties cannot reach a mutually agreeable and enforceable replacement for such provision, then (i) such provision shall be excluded from this Agreement, (ii) the balance of the Agreement shall be interpreted as if such provision were so excluded and (iii) the balance of the Agreement shall be enforceable in accordance with its terms.</u>

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f) <u>**Counterparts**</u>**.** This Agreement may be executed in counterparts, each of which shall be deemed an original, but all of which together will constitute one and the same instrument.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(g) <u>**Arbitration**</u>**.** Any dispute or claim arising out of or in connection with any provision of this Agreement will be ﬁnally settled by binding arbitration in Puerto RTGE, in accordance with the rules of the American Arbitration Association by one arbitrator appointed in accordance with said rules. The arbitrator shall apply Puerto RTGE law, without reference to rules of conﬂicts of law or rules of statutory arbitration, to the resolution of any dispute. Judgment on the award rendered by the arbitrator may be entered in any court having jurisdiction thereof. Notwithstanding the foregoing, the parties may apply to any court of competent jurisdiction for preliminary or interim equitable relief, or to compel arbitration in accordance with this paragraph, without breach of this arbitration provision. This Section 10(g) shall not apply to the Conﬁdentiality Agreement.

<u>**Advice of Counsel**. EACH PARTY ACKNOWLEDGES THAT, IN EXECUTING THIS AGREEMENT, SUCH PARTY HAS HAD THE OPPORTUNITY TO SEEK THE ADVICE OF INDEPENDENT LEGAL COUNSEL, AND HAS READ AND UNDERSTOOD ALL OF THE TERMS AND PROVISIONS OF THIS AGREEMENT. THIS AGREEMENT SHALL NOT BE CONSTRUED AGAINST ANY PARTY BY REASON OF THE DRAFTING OR PREPARATION HEREOF.</u>

[Signature Page Follows]

The parties have executed this Agreement on the respective dates set forth below.

**AMAZE HOLDINGS INC ("COMPANY")**

<u>/s/ Aaron E. Day</u> <br> By: Aaron E. Day

Title: CEO

Address: 2901 West Coast Highway Suite 200,<br> Newport Beach, CA 92663

Date: July 11, 2025

**DNA HOLDINGS VENTURE INC. ("CONSULTANT")**

<u>/s/ Chris Miglino</u> 

By: Chris Miglino

Title: CEO

Address: 151 San Francisco #200 San Juan PR 00901

Date: July 11, 2025

[*Signature page to Consulting Agreement*]

**<u>EXHIBIT A</u>**

<u>Representative activities may include but shall not be limited to advising and assisting coordination of the following:</u>

---

| | |
|:---|:---|
| **Phase** | **Task** |
| **1. Pre Dev** | **Complete Intake Form** |
| **1. Pre Dev** | **Receive Whitepaper draft (if available)** |
| **1. Pre Dev** | **Receive business overview deck (if available)** |
| **1. Pre Dev** | **Receive business one sheet (if available)** |
| **1. Pre Dev** | **If Moves to Assess 1, DNA Analyst Report on TGE** |
| **2. Development** | **Priority: Roadshow Travel plan co development** |
| **2. Development** | **Priority: TGE Timeline co development** |
| **2. Development** | **Priority: TGE and token strategy and structuring pre vs main sale** |
| **2. Development** | **Priority: Investor deck and one sheet co drafting** |
| **2. Development** | **Additional Market and competitive research and analysis as needed** |
| <br> **2. Development** | **Reﬁne early token adopter strategy - ﬁrst 1 million users, where are there unfair competitive advantages ("Lighthouse")?** |
| **2. Development** | **Whitepaper co-drafting** |
| **2. Development** | **Identify and recruit additional advisors (if any)** |
| **2. Development** | **Introductions to investors** |
| **2. Development** | **TGE platform and ﬁt selection (Coinlist, Binance, OKx, Gate, Etc)** |
| **2. Development** | **Assist in securing Legal service provider, and Investment Bank as needed** |
| **2. Development** | **Architect tokenomics, uses and velocity** |
| **2. Development** | **Strategic Market Maker introductions** |
| **2. Development** | **Facilitate Developer & Auditor consultations** |
| **2. Development** | **Facilitate whitepaper peer review** |
| **2. Development** | **Engage Developer team, TGE token / platform engineering** |
| **3. Marketing** | **Marketing video content package\*** |
| **3. Marketing** | **Marketing, recruit/enlist authentic inﬂuencers for content marketing\* (KOLs)** |
| **3. Marketing** | **Community analytics** |
| **3. Marketing** | **Community (Telegram, Twitter, etc.) growth hacking\*** |
| **3. Marketing** | **TGE tracking sites outreach (listing)** |
| **3. Marketing** | **TGE marketing strategy** |
| **3. Marketing** | **Conferences, speaking engagements** |
| **4. TGE Launch** | **Presale Coordination** |
| **4. TGE Launch** | **Mainsale Coordination or airdrop** |

---

---

| | |
|:---|:---|
| **4. TGE Launch** | **Management of liquidity providers.** |
| **4. TGE Launch** | **Introduction to exchanges, CMC, Gecko and wallets.** |
| **4. TGE Launch** | **Management of the company's treasury.** |
| **5. Post Launch** | **Post TGE Closing, Ongoing Advisory** |
| **5. Post TGE** | **Continued market awareness** |
| **5 Post TGE** | **Discounts on any other DNA Services (MM, OTC Ops, PR, etc)** |
| **5. Post TGE** | **Create a custom "white label" wallet** |

---

**<u>EXHIBIT B</u>**

**Calendar of Events for 2025**

---

| | | | |
|:---|:---|:---|:---|
| **KBW,** **SEOUL** | <u>**KBW SEOUL KOREA**</u> | **September 22-27 2025** | **WALKERHILL HOTELS & RESORTS** |
| **TOKEN2049 SINGAPORE** | <u>**TOKEN 2049**</u><br> <u>**SINGAPORE**</u> **<u>2025</u>** | <br> **October 1-2 2025** | <br> **MARINA BAY SANDS** |
| **LONDON BLOCKCHAIN** **WEEK** | <br><u>**LBW**</u> | <br>**October 22-23 2025** | <br>**EVOLUTION LONDON** |
| **DEVCON 2025** | <u>**DEVCON 2025**</u> | **November 17-22 2025** | **LA RURAL** |
| **BITCOIN MENA** | <u>**BITCOIN MENA**</u> | **December 8-9 2025** | **ADNEC CENTER ABU DHABI** |
| **ABU DHABI FINANCE WEEK** | <u>**ABU DHABI FINANCE WEEK**</u> | <br> **December 10-12 2025** | **AL MARYAH ISLAND ADGM SQUARE** |
| **WAGMI** | <u>**WAGMI**</u> | **January 20-23 2026** | **JAMES L. KNIGHT CENTER** |

---

**Note: Conference schedule subject to change**

**EXHIBIT C COMPENSATION**

For services rendered by Consultant under this Agreement, the Company shall compensate Consultant upon signing of this Agreement as follows:

&nbsp;&nbsp;&nbsp;&nbsp;I. Advisory Services

The Consultant shall provide strategic advisory services ("Advisory Services") as outlined in Exhibits A and B, including but not limited to:

● **Crypto Strategy & Token Architecture**: Develop and advise on the Company's overall crypto strategy, including token design, cross-border stablecoin infrastructure, and Web3-native monetization models relevant to the Company's global creator commerce ecosystem.

● **E-Commerce & Web3 Integration**: Guidance on integrating blockchain and tokenized incentives into the Company's e-commerce, subscription, and syndication business lines to activate and reward sellers globally.

● **Globalization & Cross-Border Currency Solutions**: Strategic input on the design and implementation of a cross-border stablecoin or payment rail to enable seamless commerce across Amaze's 134-country user base.

● **Credibility & Visibility**: Support through public brand association, media opportunities, event participation at DNA House events, and visibility within the crypto and Web3 communities.

● **Token Launch & Market Support**: Advise on timing, structure, and execution of the Token Generation Event (TGE), including token market-making, exchange relationships, and liquidity strategies.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;II. Compensation

As consideration for advisory services rendered, Consultant shall receive **100,000 shares of common stock in Amaze Holdings Inc. (NASDAQ: AMZE)** (the "Shares"). These Shares represent a ﬁxed equity grant and are being issued as non-cash compensation in accordance with the advisory agreement between DNA Advisory and Amaze Holdings Inc.

The Shares shall be duly authorized, fully paid, and non-assessable, and delivered free and clear of any liens, encumbrances, or restrictions other than those imposed by applicable securities laws.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;III. Obligation Absolute; Liquidated Damages

The Company's obligation to issue and deliver the equity compensation stated herein is absolute and unconditional, and shall not be subject to setoﬀ, counterclaim, or delay, except as may be speciﬁcally enjoined by a court of competent jurisdiction.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;IV. Event Sponsorship and Travel

The Company agrees to sponsor select mutually agreed DNA-hosted events, with attendance and participation coordinated by mutual agreement with the Consultant. Sponsorship fees shall be mutually agreed between the Company and the Consultant and may be satisﬁed using tokens allocated under this Agreement.

The Company shall be solely responsible for its own travel-related expenses for such events, including but not limited to airfare, lodging, car rentals, and per diem allowances.

&nbsp;&nbsp;&nbsp;&nbsp;IV. Market Making Requirement

Company agrees to engage DNA Market Making as one of its market-making providers for its Token Generation Event (TGE). While Company may work with multiple market makers, engagement with DNA Market Making is a required condition of this Agreement. The commercial terms of DNA Market Making's engagement shall be no less favorable than the most favorable terms Company agrees to with any other market-making provider, on a Most Favored Nation ("MFN") basis. If Company receives a bona ﬁde oﬀer from another provider with more favorable terms, DNA Market Making shall have the right to match those terms. Company shall provide DNA Advisory with a written copy of such oﬀer, and DNA Market Making shall have ten (10) business days to elect to match.

## Exhibit 99.1

**Exhibit 99.1**

Amaze Launches Crypto Payment Strategy to Accelerate Global Creator Monetization

*Strategic partnership targets stablecoin integration, digital asset treasury solutions, and next-gen monetization for global creator economy*

**NEWPORT BEACH, Calif., July 15, 2025 – Amaze Holdings, Inc. (NYSE American: AMZE) ("Amaze")**, a global leader in creator-powered commerce, today announced a major cryptocurrency initiative designed to modernize global payments, unlock new monetization tools, and enhance the Company's financial flexibility.

This strategic initiative follows the recent launch of Amaze's Express Checkout and expanded payment offerings, underscoring the Company's assertive push to lead in both traditional and digital payment innovation.

As part of the launch, Amaze has partnered with DNA Fund—a premier digital asset advisory firm—to help design and deploy blockchain-based payment and treasury strategies.

"Partnering with DNA Fund accelerates our ability to reduce cross-border payment friction and deliver faster, more flexible solutions to our growing base of international creators," said Aaron Day, CEO of Amaze. "This partnership allows us to introduce new payment offerings for our 13 million-plus creators and brings value to the millions of visitors who come to our platform looking to buy, " Day added." It also lets us start thinking beyond payments-toward helping creators access funding and build real businesses. This is a critical step in becoming a true partner to the global creator economy."

Phase One, launching in the next 60–90 days, will focus on stablecoin integration to accelerate international payments and significantly lower transaction costs. Future phases will explore:

● Digital asset treasury management

● Creator-specific financial services (credit lines, cards, etc .)

● A potential "Amaze Coin" to drive community engagement and new monetization models.

"Amaze sits at the crossroads of commerce and community," said Brock Pierce, Chairman of DNA Fund. "We're excited to help bring new Crypto and Web3 technologies to creators— for faster payments, new funding options, and the foundation for bringing Amaze into the Web3 space. We have a long history of helping companies innovate and think Amaze is in a unique position to disrupt the creator economy through crypto."

All crypto initiatives will be developed in alignment with U.S. regulatory frameworks, with robust compliance and risk oversight throughout.

**For investor information,** please contact IR@amaze.co<br>**For press inquiries**, please contact PR@amaze.co<br>

**About Amaze:**<br> Amaze Software, Inc. is an end-to-end, creator-powered commerce platform offering tools for seamless product creation, advanced e-commerce solutions, and scalable managed services. By empowering anyone to "sell anything, anywhere," Amaze enables creators to tell their stories, cultivate deeper audience connections, and generate sustainable income through shoppable, authentic experiences. Discover more at www.amaze.co.

**About DNA Holdings:**

DNA Holdings Venture Inc. is dedicated to pioneering the next wave of financial innovation through the convergence of Web3, cryptocurrency, AI, and capital markets. Our goal is to foster an ecosystem where advanced fund management, strategic advisory, and visionary infrastructure solutions for AI thrive. Find out more at dna.fund

**Cautionary Note Regarding Forward-Looking Statements**<br> This press release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act and Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act"). These statements relate to future events and developments or to our future operating or financial performance, are subject to risks and uncertainties and are based on estimates and assumptions. Forward-looking statements may include, but are not limited to, statements about our crypto strategies, including digital asset treasury management and "Amaze Coin," creator specific financial services, stablecoin integration, strategies, initiatives, growth, revenues, expenditures, the size of our market, our plans and objectives for future operations, and future financial and business performance. These statements can be identified by words such as such as "may," "might," "should," "would," "could," "expect," "plan," "anticipate," "intend," "believe," "estimate," "predict," "potential" or "continue," and are based our current expectations and views concerning future events and developments and their potential effects on us.<br>These statements are subject to known and unknown risks, uncertainties and assumptions that could cause actual results to differ materially from those projected or otherwise implied by the forward-looking statement. These risks include: our ability to execute our plans and strategies; our limited operating history and history of losses; crypto strategies,including digital asset treasury management and "Amaze Coin," creator specific financial services, stablecoin integration, our financial position and need for additional capital; our ability to attract and retain our creator base and expand the range of products available for sale; we may experience difficulties in managing our growth and expenses; we may not keep pace with technological advances; there may be undetected errors or defects in our software or issues related to data computing, processing or storage; our reliance on third parties to provide key services for our business, including cloud hosting, marketing platforms, payment providers and network providers; failure to maintain or enhance our brand; our ability to protect our intellectual property; significant interruptions, delays or outages in services from our platform; significant data breach or disruption of the information technology systems or networks and cyberattacks; risks associated with international operations; general economic and competitive factors affecting our business generally; changes in laws and regulations, including those related to privacy, online liability, consumer protection, and financial services; our dependence on senior management and other key personnel; and our ability to attract, retain and motivate qualified personnel and senior management.<br>Additional risks and uncertainties that could cause actual outcomes and results to differ materially from those contemplated by the forward-looking statements are included in our Annual Report on Form 10-K, Quarterly Reports on Form 10-Q and other future filings and reports that we file with the Securities and Exchange Commission (SEC) from time to time. Given these risks and uncertainties, you should not place undue reliance on these forward-looking statements. Also, these forward-looking statements represent our estimates and assumptions only as of the date of the press release. Unless required by law, we undertake no obligation to update or revise any forward-looking statements to reflect new information or future events or developments.